Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Better Therapeutics Inc (BTTX)

Better Therapeutics Inc (BTTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Wall Street - shutterstock_1321462394
Stocks Move Higher Before the Open as Investors Weigh Fed Comments, U.S. CPI Looms Barchart - Tue Jul 11, 2023

September S&P 500 futures (ESU23) are up +0.10%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.13% this morning after three major U.S. benchmark indices ended the regular session higher as...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
IEP : 16.54 (-0.87%)
INTC : 32.02 (+2.53%)
QCOM : 205.75 (+0.95%)
CAVA : 94.99 (+0.07%)
FMC : 55.12 (-0.97%)
GOOGL : 190.60 (+2.57%)
AMZN : 200.00 (+1.22%)
DTG.D.DX : 36.400 (-0.19%)
BTTX : 0.0144 (+44.00%)
WDFC : 214.02 (+0.27%)
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 Business Wire - Thu May 4, 2023

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the...

BTTX : 0.0144 (+44.00%)
Better Therapeutics Announces $6.5MM Private Placement Business Wire - Thu Apr 6, 2023

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address...

BTTX : 0.0144 (+44.00%)
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates Business Wire - Thu Mar 30, 2023

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address...

BTTX : 0.0144 (+44.00%)
Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 Business Wire - Thu Mar 23, 2023

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the...

BTTX : 0.0144 (+44.00%)
Better Therapeutics to Participate in Two Upcoming Investor Conferences Business Wire - Thu Feb 9, 2023

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the...

BTTX : 0.0144 (+44.00%)
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results Business Wire - Thu Dec 8, 2022

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today...

BTTX : 0.0144 (+44.00%)
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Fri Dec 2, 2022

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

BTTX : 0.0144 (+44.00%)
Better Therapeutics to Participate in BTIG Digital Health Forum Business Wire - Tue Nov 15, 2022

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

BTTX : 0.0144 (+44.00%)
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates Business Wire - Mon Nov 14, 2022

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic...

BTTX : 0.0144 (+44.00%)

Barchart Exclusives

These 3 High-yielding Dividend Aristocrats Are Also Up 10% YTD Barchart - Fri Jul 5, 6:00PM CDT
On the hunt for quality companies with positive price performance? These 3 are up 10% YTD and offer above-average yields. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot